Palmetto Issuing ‘Z-Codes’ to Track Molecular Dx Utilization, Gather Data CPT Codes Can’t Provide
Posted in Cost and Quality Improvement, Matthew Zubiller, Personalized Medicine/Molecular Diagnostics (MDx), Point-of-Care Decision Management on December 5th, 2011 by Marian Mostovy – Be the first to commentOn November 16, 2011, GenomeWeb published an article on how a Medicare contractor, Palmetto GBA, will be implementing the McKesson Diagnostics Exchange solution as part of Medicare’s program aimed at gaining more insight into molecular diagnostics reimbursed through Medicare. Palmetto GBA will use the McKesson solution to help collect evidentiary and utilization information about the molecular tests that labs submit for coverage, and will also require labs to obtain a unique identifier, called a Z-Code, to track the utilization of specific tests. In the article, Matthew Zubiller, vice president of Decision Management at McKesson Health Solutions, comments on how Palmetto GBA’s efforts will help bring “transparency, clarity, and simplicity” to the process of Medicare reimbursement for molecular diagnostics.
